RESULTS FROM A 52-WEEK RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDYOFA NOVEL, INTRA-ARTICULAR WNT PATHWAY INHIBITOR (SM04690) FOR THE TREATMENT OF KNEE OSTEOARTHRITIS

被引：0
|
作者：
Yazici, Y. [1 ]
McAlindon, T. [2 ]
Gibofsky, A. [3 ,4 ]
Lane, N. [5 ]
Clauw, D. [6 ]
Grifman, M.
Swearingen, C. [1 ]
DiFrancesco, A. [1 ]
Tambiah, J. [1 ]
Hochberg, M. [7 ]
机构：
[1] Samumed LLC, San Diego, CA USA
[2] Tufts Med Ctr, Boston, MA 02111 USA
[3] Weill Cornell Med, New York, NY USA
[4] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA
[5] Univ Calif Davis, Davis, CA 95616 USA
[6] Univ Michigan, Ann Arbor, MI 48109 USA
[7] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
来源：
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
432
引用
收藏
页码：S137 / S137
页数：1
相关论文
共 50 条
  • [41] RESULTS FROM A SINGLE CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF THE EFFICACY AND SAFETY OF INTRA-ARTICULAR ONABOTULINUMTOXINA FOR OSTEOARTHRITIS KNEE PAIN
    Kalunian, K. C.
    Arendt-Nielsen, L.
    Turkel, C. C.
    DeGryse, R.
    McAlindon, T. E.
    Boon, A. J.
    Jiang, G. -L.
    OSTEOARTHRITIS AND CARTILAGE, 2014, 22 : S192 - S192
  • [42] Comparison between intra-articular ozone and placebo in the treatment of knee osteoarthritis: A randomized, double-blinded, placebo-controlled study
    Lopes de Jesus, Carlos Cesar
    dos Santos, Fania Cristina
    Oliveira Bueno de Jesus, Luciana Maria
    Monteiro, Iara
    Sousa Castro Sant'Ana, Maria Sonia
    Moca Trevisani, Virginia Fernandes
    PLOS ONE, 2017, 12 (07):
  • [43] Effects of Evolocumab Treatment on Serum Adrenal and Gonadal Hormone Levels: Results from the 52-week, Phase 3, Double-blind, Randomized, Placebo-controlled DESCARTES Study
    Blom, Dirk J.
    Djedjos, C. Stephen
    Tsirtsonis, Kate
    Wasserman, Scott M.
    Scott, Rob
    Roth, Eli
    CIRCULATION, 2014, 130
  • [44] EFFECTS OF EVOLOCUMAB (AMG 145) TREATMENT ON VITAMIN E LEVELS: RESULTS FROM THE 52-WEEK PHASE 3 DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED DESCARTES STUDY
    Blom, Dirk
    Monsalvo, Maria Laura
    Tsirtsonis, Kate
    Wasserman, Scott
    Scott, Robert
    Roth, Eli
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A1367 - A1367
  • [45] MERIDIAN: 52-week results from a phase 2, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of pegcetacoplan in people with amyotrophic lateral sclerosis
    Maragakis, Nicholas J.
    Estol, Conrado J.
    Jain, Gayatri
    Mandrioli, Jessica
    Petri, Susanne
    van den Berg, Leonard H.
    Kreisl, William Charles
    Zhang, Yiwei
    Kuzma-Kozakiewicz, Magdalena
    MUSCLE & NERVE, 2023, 68 : S67 - S68
  • [46] The Novel, Intra-articular CLK/DYRK1A Inhibitor Lorecivivint (LOR; SM04690), Which Modulates the Wnt Pathway, Improved Responder Outcomes in Subjects with Knee Osteoarthritis: A Post Hoc Analysis from a Phase 2b Trial
    Yazici, Yusuf
    Kennedy, Sarah
    Swearingen, Chris
    Tambiah, Jeyanesh
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [47] COLCHICINE FOR TREATMENT OF OSTEOARTHRITIS OF THE KNEE (CLOAK) - A PHASE 2, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Samuels, J.
    Bomfim, F.
    Toprover, M.
    Cohen, R.
    Davis, C.
    Krasnokutsky-Samuels, S.
    Pillinger, M. H.
    OSTEOARTHRITIS AND CARTILAGE, 2020, 28 : S498 - S498
  • [48] THE NOVEL, INTRA-ARTICULAR CLK/DYRK1A INHIBITOR LORECIVIVINT (LOR; SM04690), WHICH MODULATES THE WNT PATHWAY, IMPROVED RESPONDER OUTCOMES IN SUBJECTS WITH KNEE OSTEOARTHRITIS: A POST HOC ANALYSIS FROM A PHASE 2B TRIAL
    Yazici, Y.
    Kennedy, S.
    Swearingen, C.
    Tambiah, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 809 - 810
  • [49] Results from a double blind, placebo-controlled, multicenter trial of a single intra-articular injection of anakinra (kineret®) in patients with osteoarthritis of the knee.
    Chevalier, X
    Goupille, P
    Beaulieu, AD
    Burch, FX
    Conrozier, T
    Loeuille, D
    Kivitz, AJ
    Silver, D
    Kiefer, P
    Zhou, L
    Bevirt, T
    Appleton, B
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S507 - S507
  • [50] A SINGLE CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF THE EFFICACY AND SAFETY OF INTRA-ARTICULAR ONABOTULINUMTOXINA AS TREATMENT FOR OSTEOARTHRITIS KNEE PAIN: RESULTS FROM THE EXPERIMENTAL PAIN MODELS
    Arendt-Nielsen, L.
    Jiang, G. -L
    DeGryse, R.
    Turkel, C. C.
    OSTEOARTHRITIS AND CARTILAGE, 2014, 22 : S26 - S26
12345